Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Feb 5:17:5.
doi: 10.1186/s40360-016-0047-z.

Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study

Shmeylan A Al Harbi  1 , Hani M Tamim  2 , Hasan M Al-Dorzi  3 , Musharaf Sadat  4 , Yaseen M Arabi  5
Affiliations
Randomized Controlled Trial

Association between aspirin therapy and the outcome in critically ill patients: a nested cohort study

Shmeylan A Al Harbi et al. BMC Pharmacol Toxicol. .

Abstract

Background: Antiplatelet therapy may attenuate the undesirable effects of platelets on the inflammatory cascades in critical illness. The objective of this study was to evaluate the association between aspirin therapy during intensive care unit (ICU) stay and all-cause mortality.

Methods: This was a nested cohort study within two randomized controlled trials in which all enrolled patients (N = 763) were grouped according to aspirin intake during ICU stay. The primary endpoints were all-cause ICU mortality and hospital mortality. Secondary endpoints included the development of severe sepsis during the ICU stay, ICU and hospital length of stay and the duration of mechanical ventilation. Propensity score was used to adjust for clinically and statistically relevant variables.

Results: Of the 763 patients, 154 patients (20 %) received aspirin. Aspirin therapy was not associated with a reduction in ICU mortality (adjusted OR 1.18, 95 % CI 0.69-2.02, P = 0.55) nor with hospital mortality (adjusted OR 0.95, 95 % CI 0.61-1.50, P = 0.82). Aspirin use had no preferential association with mortality among any of the study subgroups. Additionally, aspirin therapy was associated with higher risk of ICU-acquired severe sepsis, and increased mechanical ventilation duration and ICU length of stay.

Conclusion: Our study showed that the use of aspirin in critically ill patients was not associated with lower mortality, but rather with an increased morbidity.

Trial registration number: ISRCTN07413772 and ISRCTN96294863 .

PubMed Disclaimer

References

    1. Levi M. Platelets in sepsis. Hematology. 2005;10(Suppl 1):129–31. doi: 10.1080/10245330512331390177. - DOI - PubMed
    1. Vincent JL, Yagushi A, Pradier O. Platelet function in sepsis. Crit Care Med. 2002;30(5 Suppl):S313–7. doi: 10.1097/00003246-200205001-00022. - DOI - PubMed
    1. Katz JN, Kolappa KP, Becker RC. Beyond thrombosis: the versatile platelet in critical illness. Chest. 2011;139(3):658–68. doi: 10.1378/chest.10-1971. - DOI - PMC - PubMed
    1. Nguyen TC, Carcillo JA. Bench-to-bedside review: thrombocytopenia-associated multiple organ failure--a newly appreciated syndrome in the critically ill. Crit Care. 2006;10(6):235. doi: 10.1186/cc5064. - DOI - PMC - PubMed
    1. Levi M, Lowenberg EC. Thrombocytopenia in critically ill patients. Semin Thromb Hemost. 2008;34(5):417–24. doi: 10.1055/s-0028-1092871. - DOI - PubMed

Publication types

MeSH terms

Substances

Associated data